Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from DESTINATION
Titel:
Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from DESTINATION
Auteur:
Wechsler, Michael E. Stolz, Daiana Lugogo, Njira L. Caveney, Scott Almqvist, Gun Bednarczyk, Artur Kotalik, Ales Chandarana, Shradha Ambrose, Christopher S.
Verschenen in:
The journal of allergy and clinical immunology. In practice